Pharmacokinetics of Oral d-Serine in d-Amino Acid Oxidase Knockout Mice

Autor: Akira Sawa, Barbara S. Slusher, Hanna Jaaro-Peled, Ying Wu, Sandra J. Engle, Camilo Rojas, Christine A. Strick, Nicholas J. Brandon, Takashi Tsukamoto, Krystyna M. Wozniak, Ajit G. Thomas, Rana Rais
Rok vydání: 2012
Předmět:
Zdroj: Drug Metabolism and Disposition. 40:2067-2073
ISSN: 1521-009X
0090-9556
DOI: 10.1124/dmd.112.046482
Popis: D-Amino acid oxidase (DAAO) catalyzes the oxidative deamination of D-amino acids including D-serine, a full agonist at the glycine modulatory site of the N-methyl-d-aspartate (NMDA) receptor. To evaluate the significance of DAAO-mediated metabolism in the pharmacokinetics of oral D-serine, plasma D-serine levels were measured in both wild-type mice and transgenic mice lacking DAAO. Although D-serine levels were rapidly diminished in wild-type mice (t(½) = 1.2 h), sustained drug levels over the course of 4 h (t(½)10 h) were observed in mice lacking DAAO. Coadministration of D-serine with 6-chlorobenzo[d]isoxazol-3-ol (CBIO), a small-molecule DAAO inhibitor, in wild-type mice resulted in the enhancement of plasma D-serine levels, although CBIO seems to have only temporary effects on the plasma D-serine levels due to glucuronidation of the key hydroxyl group. These findings highlight the predominant role of DAAO in the clearance of D-serine from the systemic circulation. Thus, a potent DAAO inhibitor with a longer half-life should be capable of maintaining high plasma D-serine levels over a sustained period of time and might have therapeutic implications for the treatment of schizophrenia.
Databáze: OpenAIRE